News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
305,415 Results
Type
Article (10279)
Company Profile (62)
Press Release (295068)
Multimedia
Podcasts (34)
Webinars (6)
Section
Business (96154)
Career Advice (1794)
Deals (17535)
Drug Delivery (66)
Drug Development (18917)
Employer Resources (63)
FDA (6092)
Job Trends (6859)
News (144387)
Policy (13625)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1159)
Accelerated approval (17)
ADA (9)
Adcomms (9)
Allergies (71)
Alliances (28892)
ALS (67)
Alzheimer's disease (537)
Antibody-drug conjugate (ADC) (180)
Approvals (6301)
Artificial intelligence (314)
ASCO (80)
Autoimmune disease (92)
Automation (31)
Bankruptcy (123)
Best Places to Work (5653)
BIO (24)
BIOSECURE Act (11)
Biosimilars (130)
Biotechnology (37)
Bladder cancer (64)
Brain cancer (22)
Breast cancer (245)
Cancer (2048)
Cardiovascular disease (133)
Career advice (1492)
Career pathing (27)
CAR-T (87)
CDC (51)
Celiac Disease (1)
Cell therapy (306)
Cervical cancer (19)
Clinical research (17057)
Collaboration (1114)
Commercialization (1)
Company closure (2)
Compensation (816)
Complete response letters (19)
COVID-19 (927)
CRISPR (26)
C-suite (527)
Cystic fibrosis (25)
Data (2374)
Decentralized trials (1)
Denatured (7)
Depression (54)
Dermatology (37)
Diabetes (169)
Diagnostics (4104)
Digital health (33)
Diversity (5)
Diversity, equity & inclusion (15)
Drug discovery (163)
Drug pricing (114)
Drug shortages (7)
Duchenne muscular dystrophy (86)
Earnings (34074)
Editorial (34)
Employer branding (5)
Employer resources (63)
Events (35964)
Executive appointments (534)
FDA (7624)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (6)
Frontotemporal dementia (5)
Funding (634)
Gene editing (49)
Generative AI (21)
Gene therapy (210)
GLP-1 (281)
Government (2620)
Grass and pollen (6)
Guidances (239)
Healthcare (10482)
Hematology (62)
HIV (30)
Huntington's disease (11)
IgA nephropathy (26)
Immunology and inflammation (35)
Immuno-oncology (27)
Indications (65)
Infectious disease (1067)
Inflammatory bowel disease (76)
Inflation Reduction Act (12)
Influenza (57)
Intellectual property (91)
Interviews (369)
IPO (7172)
IRA (38)
Job creations (1313)
Job search strategy (1198)
JPM (12)
Kidney cancer (4)
Labor market (59)
Layoffs (148)
Leadership (20)
Legal (3026)
Liver cancer (35)
Longevity (13)
Lung cancer (280)
Lymphoma (185)
Machine learning (24)
Management (29)
Manufacturing (661)
Marketing (1)
MASH (61)
Medical affairs (1)
Medical device (6556)
Medtech (6628)
Mergers & acquisitions (11067)
Metabolic disorders (386)
mRNA (44)
Multiple sclerosis (61)
NASH (3)
Neurodegenerative disease (102)
Neuropsychiatric disorders (20)
Neuroscience (1033)
NextGen: Class of 2026 (3648)
Non-profit (2876)
Now hiring (16)
Obesity (128)
Opinion (112)
Ovarian cancer (61)
Pain (74)
Pancreatic cancer (78)
Parkinson's disease (130)
Partnered (24)
Patents (183)
Patient recruitment (190)
Peanut (20)
People (30702)
Pharmaceutical (15)
Pharmacy benefit managers (23)
Phase 1 (4719)
Phase 2 (7274)
Phase 3 (6092)
Pipeline (3789)
Policy (203)
Postmarket research (694)
Preclinical (1816)
Press Release (66)
Prostate cancer (121)
Psychedelics (22)
Radiopharmaceuticals (130)
Rare diseases (281)
Real estate (3701)
Recruiting (34)
Regulatory (10168)
Reports (23)
Research institute (1170)
Resumes & cover letters (326)
Rett syndrome (3)
RNA editing (5)
RSV (20)
Schizophrenia (58)
Series A (81)
Series B (61)
Service/supplier (13)
Sickle cell disease (38)
Special edition (10)
Spinal muscular atrophy (29)
Sponsored (21)
Startups (1455)
State (1)
Stomach cancer (2)
Supply chain (73)
Tariffs (24)
The Weekly (27)
Vaccines (312)
Venture capital (28)
Weight loss (80)
Women's health (53)
Worklife (9)
Date
Today (29)
Last 7 days (154)
Last 30 days (873)
Last 365 days (10817)
2026 (5706)
2025 (11091)
2024 (13755)
2023 (16296)
2022 (23708)
2021 (25102)
2020 (26283)
2019 (25154)
2018 (18943)
2017 (14105)
2016 (13556)
2015 (15492)
2014 (11361)
2013 (9795)
2012 (10734)
2011 (11241)
2010 (9773)
Location
Africa (429)
Alabama (25)
Alaska (5)
Arizona (122)
Arkansas (9)
Asia (29249)
Australia (3714)
California (4017)
Canada (2165)
China (712)
Colorado (257)
Connecticut (181)
Delaware (125)
Europe (42629)
Florida (649)
Georgia (150)
Hawaii (3)
Idaho (28)
Illinois (544)
India (65)
Indiana (201)
Iowa (6)
Japan (419)
Kansas (50)
Kentucky (34)
Louisiana (32)
Maine (32)
Maryland (739)
Massachusetts (2934)
Michigan (178)
Minnesota (242)
Mississippi (4)
Missouri (72)
Montana (12)
Nebraska (18)
Nevada (57)
New Hampshire (28)
New Jersey (1560)
New Mexico (18)
New York (1081)
North Carolina (847)
North Dakota (6)
Northern California (1779)
Ohio (217)
Oklahoma (15)
Oregon (16)
Pennsylvania (1103)
Puerto Rico (18)
Rhode Island (22)
South America (622)
South Carolina (21)
South Dakota (1)
Southern California (1825)
Tennessee (114)
Texas (728)
United States (16614)
Utah (120)
Vermont (2)
Virginia (142)
Washington D.C. (35)
Washington State (342)
West Virginia (4)
Wisconsin (76)
Wyoming (1)
305,415 Results for "tip knowledge services pvt ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Breckenridge Pharmaceutical enters strategic partnership with Maiva Pharma Pvt. Ltd.
March 11, 2026
·
2 min read
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Termination of Liquidity Provision Service
May 6, 2026
·
2 min read
Press Releases
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
November 6, 2025
·
3 min read
Career Advice
AI Tips and Prompts That Can Take Your Job Search to the Next Level
While you should never rely solely on AI tools when applying for jobs, they can greatly benefit the application process. Recruiting expert Bryan Blair discusses how using large language models can set you apart from the competition and includes a prompt framework to get you started.
February 26, 2026
·
8 min read
·
Bryan Blair
Policy
FDA taps prior knowledge to expedite cell and gene therapy development
A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns surface about the politicization of the agency.
June 3, 2026
·
12 min read
·
BioSpace Editorial Staff
Press Releases
Faron Pharmaceuticals Ltd: Registration of Treasury Shares
June 11, 2026
·
2 min read
Career Advice
Should biopharma professionals negotiate job offers in an employer’s market?
Three experts discuss whether biotech and pharma professionals should try to convince employers to adjust employment offers, mistakes people make during the process and tips for getting it right.
May 28, 2026
·
6 min read
·
Angela Gabriel
Press Releases
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
May 20, 2026
·
7 min read
Psychedelics
Psychedelics Space at a ‘Tipping Point’ as Compass, Definium Gear Up To File for Approval
With Lykos’ regulatory failure now squarely in the rearview mirror, Compass Pathways and Definium are leading what one analyst suspects will be “a very big year for psychedelics.”
February 2, 2026
·
7 min read
·
Heather McKenzie
1 of 30,542
Next
